Stocks
GlaxoSmithKline (GSK) FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF, £ | ? | 5 021 000 000 | 5 145 000 000 | 5 145 000 000 | 4 004 000 000 | 4 004 000 000 | 6 467 000 000 | ||
| Changes by years, y/y, % | 0% | +2% | 0% | -22% | 0% | -9.6% | |||
GlaxoSmithKline. FCF, £
GlaxoSmithKline. FCF, changes, %
GlaxoSmithKline. FCF, sum by quarters, £
GlaxoSmithKline (GSK) FCF US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| FCF, £ | ? | 772 000 000 | 1 715 000 000 | 2 188 000 000 | 2 188 000 000 | 376 000 000 | 6 467 000 000 | |
| Changes by years, y/y, % | -36% | +104% | +90% | +90% | -179% | |||
| Changes by quarters, q/q, % | 0% | +122% | +28% | 0% | -83% | |||
